EA
UTMD icon

Emerald Acquisition’s Utah Medical Products UTMD Stock Holding History

Emerald Acquisition’s Portfolio UTMD Stock Details UTMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		$2.43M Buy
40,681
+10,021
+33% +$637K ﹤0.01% 1647
2016
Q2 		$1.93M Buy
+30,660
New +$1.98M ﹤0.01% 1846

Other funds holding UTMD

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
NTCM
Nine Ten Capital Management Chicago, Illinois $315M AUM 62.95% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return

Emerald Acquisition's UTMD Position: Q3 2016 in Review

Emerald Acquisition increased its Utah Medical Products (UTMD) stake by 33% in Q3 2016, buying an estimated $637K and bringing the position to 40,681 shares worth $2.43M. The position accounts for ﹤0.01% of the portfolio, ranked #1647.

Emerald Acquisition first reported a position in UTMD in Q2 2016 and has held it in 2 quarters since. 79 funds tracked by Wall St. Rank hold UTMD as of Q3 2016.

  • Emerald Acquisition held 40,681 shares of Utah Medical Products worth $2.43M as of Q3 2016.
  • Emerald Acquisition bought 10,021 Utah Medical Products shares in Q3 2016, an estimated $637K.
  • Utah Medical Products made up ﹤0.01% of Emerald Acquisition's portfolio in Q3 2016, its #1647 holding.
  • Emerald Acquisition first reported a position in Utah Medical Products in Q2 2016 and has held it in 2 quarters since.
  • 79 funds tracked by Wall St. Rank held Utah Medical Products as of Q3 2016.

Based on Emerald Acquisition's 13F filing for Q3 2016, filed 9 Nov 2016.